InvestorsHub Logo
Followers 64
Posts 6479
Boards Moderated 0
Alias Born 03/17/2017

Re: None

Tuesday, 12/12/2017 7:50:55 AM

Tuesday, December 12, 2017 7:50:55 AM

Post# of 463680
Lets look forward to 2018 and leave 2017 behind us. Now what to expect in 2018.
1. Let's take Misslings word for it this time and let's say Rett trial will start on Feb 1 2018. 90% Sure. The trial takes 3 months, read out 1 month more that's June 1 trial data when we have positive news or not. 90% sure. I estimate that 2-73 will have a positive readout for Rett at 75% change.

2. Then Parkinson trial starting Q1 50%, 50% but ok lets say it starts in May 2018. Same here trial takes 3 months read out 1 months so read out before end of summer 90% sure. I estimate that 2-73 will have a positive readout for Parkinson at also 75% change.

3. Start Alzheimer trial, hell lets say June 2018 or before that. 100%

4. The CFO confirmed that Anavex has enough budget to finance all three trials in 2018 so no more dilution... 70% change

If Missiling and the Anavex CFO shave spoken true words (..) and if the trials have positive readouts (and we believe the science right cause if you dont get out now)... then there is a very big and realistic change that Anavex will be worth between 2 - 3 billion at the end of summer 2018 IMO.

With $ 3,5 SP now to $ 50 potentially in the described situation before the end of summer 2018, thats one hell of a ride with a big change of success. Not a bad investment at all at $3,5

$ 50 SP estimate is all without possible MS study starting, Biogen etc. So 2018 is the year for Anavex forget 2017... IMO

Comments welcome...

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News